Figure S4 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy Article Swipe

View

Matheus Henrique Dias , Anoek Friskes , Siying Wang , João M. Fernandes Neto , Frank van Gemert , Soufiane Mourragui , Chrysa Papagianni , Hendrik J. Kuiken , Sara Mainardi , Daniel Álvarez‐Villanueva , Cor Lieftink , Ben Morris , Anna Dekker , Emma van Dijk , Lieke H.S. Wilms , Marcelo S. da Silva , Robin A. Jansen , Antonio Mulero‐Sánchez , Elke Malzer , August Vidal , Cristina Santos , Ramón Salazar , Rosangela A.M. Wailemann , Thompson E.P. Torres , Giulia De Conti , Jonne A. Raaijmakers , Pétur Snæbjörnsson , Shengxian Yuan , Wenxin Qin , John S. Kovach , Hugo A. Armelin , Hein te Riele , Alexander van Oudenaarden , Haojie Jin , Roderick L. Beijersbergen , Alberto Villanueva , René H. Medema , René Bernards ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1158/2159-8290.26134855.v1

Figure S4: Combined toxicity of LB-100 and Adavosertib in CRC models (A) Dose-response assays show the effect of Adavosertib in 7 CRC models. Cell viability was estimated by resazurin fluorescence after 5 days in the presence of the drug or DMSO control. The normalized values are plotted. (B) Long-term viability assays show 7 CRC models treated with LB-100 or Adavosertib at the indicated concentrations. Treatments were refreshed every 2-3 days, and the cells were grown for 10-14 days before fixing, staining, and imaging. (C) IncuCyte-based proliferation assays from 7 CRC models in the absence or presence of LB-100, Adavosertib, or the combination at the indicated concentrations. (D) Dose-response assays show the toxicity of LB-100 and Adavosertib in BJ and HaCaT cells compared to the average across the 7 CRC cell lines listed in the supplementary table S1. Cell viability was estimated by resazurin fluorescence after 5 days in the presence of the drug or DMSO control. The normalized values are plotted. (E) Synergy matrices and scores for the combination of LB-100 and Adavosertib in BJ and HaCaT cells. Cells were treated with 5 concentrations of LB-100 (1, 2, 3, 4, and 5 µM) or Adavosertib (100, 200, 300, 400, and 500 nM) and all respective permutations for 4 days. The percentage of cell viability for each condition was estimated by resazurin fluorescence and normalized to DMSO controls. Synergyfinder.org web tool was used to calculate the ZIP synergy scores and generate the plots.

Related Topics

Cancer

Medicine

Internal Medicine

Concepts

Cancer Cancer research Psychology Political science Medicine Internal medicine

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/2159-8290.26134855.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4400214448

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4400214448

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/2159-8290.26134855.v1

Digital Object Identifier
Title: Figure S4 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2024

Year of publication
Publication date: 2024-07-01

Full publication date if available
Authors: Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M. Fernandes Neto, Frank van Gemert, Soufiane Mourragui, Chrysa Papagianni, Hendrik J. Kuiken, Sara Mainardi, Daniel Álvarez‐Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H.S. Wilms, Marcelo S. da Silva, Robin A. Jansen, Antonio Mulero‐Sánchez, Elke Malzer, August Vidal, Cristina Santos, Ramón Salazar, Rosangela A.M. Wailemann, Thompson E.P. Torres, Giulia De Conti, Jonne A. Raaijmakers, Pétur Snæbjörnsson, Shengxian Yuan, Wenxin Qin, John S. Kovach, Hugo A. Armelin, Hein te Riele, Alexander van Oudenaarden, Haojie Jin, Roderick L. Beijersbergen, Alberto Villanueva, René H. Medema, René Bernards

List of authors in order
Landing page: https://doi.org/10.1158/2159-8290.26134855.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/2159-8290.26134855.v1

Direct OA link when available
Concepts: Cancer, Cancer research, Psychology, Political science, Medicine, Internal medicine

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4400214448
doi	https://doi.org/10.1158/2159-8290.26134855.v1
ids.doi	https://doi.org/10.1158/2159-8290.26134855.v1
ids.openalex	https://openalex.org/W4400214448
fwci	0.0
type	preprint
title	Figure S4 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T12829
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9448000192642212
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2740
topics[0].subfield.display_name	Pulmonary and Respiratory Medicine
topics[0].display_name	Advanced Breast Cancer Therapies
topics[1].id	https://openalex.org/T11752
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9125000238418579
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Cancer Treatment and Pharmacology
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C121608353
concepts[0].level	2
concepts[0].score	0.5972890853881836
concepts[0].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[0].display_name	Cancer
concepts[1].id	https://openalex.org/C502942594
concepts[1].level	1
concepts[1].score	0.44236454367637634
concepts[1].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[1].display_name	Cancer research
concepts[2].id	https://openalex.org/C15744967
concepts[2].level	0
concepts[2].score	0.3677231967449188
concepts[2].wikidata	https://www.wikidata.org/wiki/Q9418
concepts[2].display_name	Psychology
concepts[3].id	https://openalex.org/C17744445
concepts[3].level	0
concepts[3].score	0.33590757846832275
concepts[3].wikidata	https://www.wikidata.org/wiki/Q36442
concepts[3].display_name	Political science
concepts[4].id	https://openalex.org/C71924100
concepts[4].level	0
concepts[4].score	0.29170840978622437
concepts[4].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[4].display_name	Medicine
concepts[5].id	https://openalex.org/C126322002
concepts[5].level	1
concepts[5].score	0.2444470226764679
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[5].display_name	Internal medicine
keywords[0].id	https://openalex.org/keywords/cancer
keywords[0].score	0.5972890853881836
keywords[0].display_name	Cancer
keywords[1].id	https://openalex.org/keywords/cancer-research
keywords[1].score	0.44236454367637634
keywords[1].display_name	Cancer research
keywords[2].id	https://openalex.org/keywords/psychology
keywords[2].score	0.3677231967449188
keywords[2].display_name	Psychology
keywords[3].id	https://openalex.org/keywords/political-science
keywords[3].score	0.33590757846832275
keywords[3].display_name	Political science
keywords[4].id	https://openalex.org/keywords/medicine
keywords[4].score	0.29170840978622437
keywords[4].display_name	Medicine
keywords[5].id	https://openalex.org/keywords/internal-medicine
keywords[5].score	0.2444470226764679
keywords[5].display_name	Internal medicine
language	en
locations[0].id	doi:10.1158/2159-8290.26134855.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/2159-8290.26134855.v1
locations[1].id	pmh:oai:figshare.com:article/26134855
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Image
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/figure/Figure_S4_from_Paradoxical_Activation_of_Oncogenic_Signaling_as_a_Cancer_Treatment_Strategy/26134855
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5085217090
authorships[0].author.orcid	https://orcid.org/0000-0002-2961-1142
authorships[0].author.display_name	Matheus Henrique Dias
authorships[0].author_position	first
authorships[0].raw_author_name	Matheus Henrique Dias
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5090302884
authorships[1].author.orcid	https://orcid.org/0000-0002-9845-3715
authorships[1].author.display_name	Anoek Friskes
authorships[1].author_position	middle
authorships[1].raw_author_name	Anoek Friskes
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5009783386
authorships[2].author.orcid	https://orcid.org/0000-0003-0810-8828
authorships[2].author.display_name	Siying Wang
authorships[2].author_position	middle
authorships[2].raw_author_name	Siying Wang
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5079694182
authorships[3].author.orcid	https://orcid.org/0000-0002-0549-8835
authorships[3].author.display_name	João M. Fernandes Neto
authorships[3].author_position	middle
authorships[3].raw_author_name	Joao M. Fernandes Neto
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5102915373
authorships[4].author.orcid	https://orcid.org/0009-0000-6076-9469
authorships[4].author.display_name	Frank van Gemert
authorships[4].author_position	middle
authorships[4].raw_author_name	Frank van Gemert
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5056948757
authorships[5].author.orcid	https://orcid.org/0000-0001-6920-2696
authorships[5].author.display_name	Soufiane Mourragui
authorships[5].author_position	middle
authorships[5].raw_author_name	Soufiane Mourragui
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5061571526
authorships[6].author.orcid
authorships[6].author.display_name	Chrysa Papagianni
authorships[6].author_position	middle
authorships[6].raw_author_name	Chrysa Papagianni
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5049897931
authorships[7].author.orcid	https://orcid.org/0000-0002-1015-4607
authorships[7].author.display_name	Hendrik J. Kuiken
authorships[7].author_position	middle
authorships[7].raw_author_name	Hendrik J. Kuiken
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5005545073
authorships[8].author.orcid	https://orcid.org/0000-0001-7255-6153
authorships[8].author.display_name	Sara Mainardi
authorships[8].author_position	middle
authorships[8].raw_author_name	Sara Mainardi
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5076778474
authorships[9].author.orcid	https://orcid.org/0000-0003-2585-622X
authorships[9].author.display_name	Daniel Álvarez‐Villanueva
authorships[9].author_position	middle
authorships[9].raw_author_name	Daniel Alvarez-Villanueva
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5084927840
authorships[10].author.orcid	https://orcid.org/0000-0002-2754-4150
authorships[10].author.display_name	Cor Lieftink
authorships[10].author_position	middle
authorships[10].raw_author_name	Cor Lieftink
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5044639892
authorships[11].author.orcid	https://orcid.org/0000-0002-9850-6071
authorships[11].author.display_name	Ben Morris
authorships[11].author_position	middle
authorships[11].raw_author_name	Ben Morris
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5051328586
authorships[12].author.orcid	https://orcid.org/0000-0002-1000-3788
authorships[12].author.display_name	Anna Dekker
authorships[12].author_position	middle
authorships[12].raw_author_name	Anna Dekker
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5043411351
authorships[13].author.orcid	https://orcid.org/0009-0004-1595-2327
authorships[13].author.display_name	Emma van Dijk
authorships[13].author_position	middle
authorships[13].raw_author_name	Emma van Dijk
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5023532676
authorships[14].author.orcid	https://orcid.org/0009-0000-1795-6752
authorships[14].author.display_name	Lieke H.S. Wilms
authorships[14].author_position	middle
authorships[14].raw_author_name	Lieke H.S. Wilms
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5044344396
authorships[15].author.orcid	https://orcid.org/0000-0003-4203-9299
authorships[15].author.display_name	Marcelo S. da Silva
authorships[15].author_position	middle
authorships[15].raw_author_name	Marcelo S. da Silva
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5000562650
authorships[16].author.orcid	https://orcid.org/0009-0001-7272-234X
authorships[16].author.display_name	Robin A. Jansen
authorships[16].author_position	middle
authorships[16].raw_author_name	Robin A. Jansen
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5047045246
authorships[17].author.orcid	https://orcid.org/0000-0003-1668-7022
authorships[17].author.display_name	Antonio Mulero‐Sánchez
authorships[17].author_position	middle
authorships[17].raw_author_name	Antonio Mulero-Sánchez
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5055213329
authorships[18].author.orcid	https://orcid.org/0000-0002-8529-8234
authorships[18].author.display_name	Elke Malzer
authorships[18].author_position	middle
authorships[18].raw_author_name	Elke Malzer
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5003826728
authorships[19].author.orcid	https://orcid.org/0000-0001-5727-2099
authorships[19].author.display_name	August Vidal
authorships[19].author_position	middle
authorships[19].raw_author_name	August Vidal
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5060569859
authorships[20].author.orcid	https://orcid.org/0000-0002-9854-5097
authorships[20].author.display_name	Cristina Santos
authorships[20].author_position	middle
authorships[20].raw_author_name	Cristina Santos
authorships[20].is_corresponding	False
authorships[21].author.id	https://openalex.org/A5035175323
authorships[21].author.orcid	https://orcid.org/0000-0001-9419-6232
authorships[21].author.display_name	Ramón Salazar
authorships[21].author_position	middle
authorships[21].raw_author_name	Ramón Salazar
authorships[21].is_corresponding	False
authorships[22].author.id	https://openalex.org/A5037639617
authorships[22].author.orcid	https://orcid.org/0000-0003-4909-9657
authorships[22].author.display_name	Rosangela A.M. Wailemann
authorships[22].author_position	middle
authorships[22].raw_author_name	Rosangela A.M. Wailemann
authorships[22].is_corresponding	False
authorships[23].author.id	https://openalex.org/A5028091390
authorships[23].author.orcid	https://orcid.org/0000-0003-1425-9358
authorships[23].author.display_name	Thompson E.P. Torres
authorships[23].author_position	middle
authorships[23].raw_author_name	Thompson E.P. Torres
authorships[23].is_corresponding	False
authorships[24].author.id	https://openalex.org/A5035090455
authorships[24].author.orcid	https://orcid.org/0000-0002-2647-228X
authorships[24].author.display_name	Giulia De Conti
authorships[24].author_position	middle
authorships[24].raw_author_name	Giulia De Conti
authorships[24].is_corresponding	False
authorships[25].author.id	https://openalex.org/A5022915602
authorships[25].author.orcid	https://orcid.org/0000-0003-1759-8347
authorships[25].author.display_name	Jonne A. Raaijmakers
authorships[25].author_position	middle
authorships[25].raw_author_name	Jonne A. Raaijmakers
authorships[25].is_corresponding	False
authorships[26].author.id	https://openalex.org/A5087708892
authorships[26].author.orcid	https://orcid.org/0000-0002-1086-8108
authorships[26].author.display_name	Pétur Snæbjörnsson
authorships[26].author_position	middle
authorships[26].raw_author_name	Petur Snaebjornsson
authorships[26].is_corresponding	False
authorships[27].author.id	https://openalex.org/A5022374609
authorships[27].author.orcid	https://orcid.org/0000-0002-4883-0156
authorships[27].author.display_name	Shengxian Yuan
authorships[27].author_position	middle
authorships[27].raw_author_name	Shengxian Yuan
authorships[27].is_corresponding	False
authorships[28].author.id	https://openalex.org/A5030429117
authorships[28].author.orcid	https://orcid.org/0000-0002-1989-3027
authorships[28].author.display_name	Wenxin Qin
authorships[28].author_position	middle
authorships[28].raw_author_name	Wenxin Qin
authorships[28].is_corresponding	False
authorships[29].author.id	https://openalex.org/A5112006097
authorships[29].author.orcid
authorships[29].author.display_name	John S. Kovach
authorships[29].author_position	middle
authorships[29].raw_author_name	John S. Kovach
authorships[29].is_corresponding	False
authorships[30].author.id	https://openalex.org/A5072122806
authorships[30].author.orcid	https://orcid.org/0000-0001-9557-0804
authorships[30].author.display_name	Hugo A. Armelin
authorships[30].author_position	middle
authorships[30].raw_author_name	Hugo A. Armelin
authorships[30].is_corresponding	False
authorships[31].author.id	https://openalex.org/A5002551113
authorships[31].author.orcid	https://orcid.org/0000-0003-0255-4042
authorships[31].author.display_name	Hein te Riele
authorships[31].author_position	middle
authorships[31].raw_author_name	Hein te Riele
authorships[31].is_corresponding	False
authorships[32].author.id	https://openalex.org/A5035202405
authorships[32].author.orcid	https://orcid.org/0000-0002-9442-3551
authorships[32].author.display_name	Alexander van Oudenaarden
authorships[32].author_position	middle
authorships[32].raw_author_name	Alexander van Oudenaarden
authorships[32].is_corresponding	False
authorships[33].author.id	https://openalex.org/A5010924102
authorships[33].author.orcid	https://orcid.org/0000-0001-9295-1951
authorships[33].author.display_name	Haojie Jin
authorships[33].author_position	middle
authorships[33].raw_author_name	Haojie Jin
authorships[33].is_corresponding	False
authorships[34].author.id	https://openalex.org/A5058317809
authorships[34].author.orcid	https://orcid.org/0000-0003-0116-4130
authorships[34].author.display_name	Roderick L. Beijersbergen
authorships[34].author_position	middle
authorships[34].raw_author_name	Roderick L. Beijersbergen
authorships[34].is_corresponding	False
authorships[35].author.id	https://openalex.org/A5004386682
authorships[35].author.orcid	https://orcid.org/0000-0001-5164-0006
authorships[35].author.display_name	Alberto Villanueva
authorships[35].author_position	middle
authorships[35].raw_author_name	Alberto Villanueva
authorships[35].is_corresponding	False
authorships[36].author.id	https://openalex.org/A5074565662
authorships[36].author.orcid	https://orcid.org/0000-0002-6754-0381
authorships[36].author.display_name	René H. Medema
authorships[36].author_position	middle
authorships[36].raw_author_name	Rene H. Medema
authorships[36].is_corresponding	False
authorships[37].author.id	https://openalex.org/A5028266055
authorships[37].author.orcid	https://orcid.org/0000-0001-8677-3423
authorships[37].author.display_name	René Bernards
authorships[37].author_position	last
authorships[37].raw_author_name	Rene Bernards
authorships[37].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/2159-8290.26134855.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Figure S4 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T12829
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9448000192642212
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2740
primary_topic.subfield.display_name	Pulmonary and Respiratory Medicine
primary_topic.display_name	Advanced Breast Cancer Therapies
related_works	https://openalex.org/W4391375266, https://openalex.org/W2748952813, https://openalex.org/W2931662336, https://openalex.org/W2077865380, https://openalex.org/W2765597752, https://openalex.org/W2134894512, https://openalex.org/W2083375246, https://openalex.org/W2067108088, https://openalex.org/W2085372204, https://openalex.org/W4391301621
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/2159-8290.26134855.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/2159-8290.26134855.v1
primary_location.id	doi:10.1158/2159-8290.26134855.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/2159-8290.26134855.v1
publication_date	2024-07-01
publication_year	2024
referenced_works_count	0
abstract_inverted_index.4	207
abstract_inverted_index.5	31, 145, 182, 191
abstract_inverted_index.7	20, 52, 88, 127
abstract_inverted_index.2,	187
abstract_inverted_index.3,	188
abstract_inverted_index.4,	189
abstract_inverted_index.BJ	117, 174
abstract_inverted_index.at	60, 102
abstract_inverted_index.by	27, 141, 219
abstract_inverted_index.in	8, 19, 33, 91, 116, 132, 147, 173
abstract_inverted_index.of	4, 17, 36, 96, 112, 150, 169, 184, 211
abstract_inverted_index.or	39, 58, 94, 99, 153, 193
abstract_inverted_index.to	122, 224, 232
abstract_inverted_index.(1,	186
abstract_inverted_index.(A)	11
abstract_inverted_index.(B)	47
abstract_inverted_index.(C)	83
abstract_inverted_index.(D)	106
abstract_inverted_index.(E)	161
abstract_inverted_index.2-3	68
abstract_inverted_index.500	200
abstract_inverted_index.CRC	9, 21, 53, 89, 128
abstract_inverted_index.S1.	136
abstract_inverted_index.S4:	1
abstract_inverted_index.The	42, 156, 209
abstract_inverted_index.ZIP	235
abstract_inverted_index.all	203
abstract_inverted_index.and	6, 70, 81, 114, 118, 164, 171, 175, 190, 199, 202, 222, 238
abstract_inverted_index.are	45, 159
abstract_inverted_index.for	75, 166, 206, 214
abstract_inverted_index.nM)	201
abstract_inverted_index.the	15, 34, 37, 61, 71, 92, 100, 103, 110, 123, 126, 133, 148, 151, 167, 234, 240
abstract_inverted_index.was	25, 139, 217, 230
abstract_inverted_index.web	228
abstract_inverted_index.200,	196
abstract_inverted_index.300,	197
abstract_inverted_index.400,	198
abstract_inverted_index.Cell	23, 137
abstract_inverted_index.DMSO	40, 154, 225
abstract_inverted_index.cell	129, 212
abstract_inverted_index.days	32, 77, 146
abstract_inverted_index.drug	38, 152
abstract_inverted_index.each	215
abstract_inverted_index.from	87
abstract_inverted_index.show	14, 51, 109
abstract_inverted_index.tool	229
abstract_inverted_index.used	231
abstract_inverted_index.were	65, 73, 179
abstract_inverted_index.with	56, 181
abstract_inverted_index.µM)	192
abstract_inverted_index.(100,	195
abstract_inverted_index.10-14	76
abstract_inverted_index.Cells	178
abstract_inverted_index.HaCaT	119, 176
abstract_inverted_index.after	30, 144
abstract_inverted_index.cells	72, 120
abstract_inverted_index.days,	69
abstract_inverted_index.days.	208
abstract_inverted_index.every	67
abstract_inverted_index.grown	74
abstract_inverted_index.lines	130
abstract_inverted_index.table	135
abstract_inverted_index.LB-100	5, 57, 113, 170, 185
abstract_inverted_index.across	125
abstract_inverted_index.assays	13, 50, 86, 108
abstract_inverted_index.before	78
abstract_inverted_index.cells.	177
abstract_inverted_index.effect	16
abstract_inverted_index.listed	131
abstract_inverted_index.models	10, 54, 90
abstract_inverted_index.scores	165, 237
abstract_inverted_index.values	44, 158
abstract_inverted_index.LB-100,	97
abstract_inverted_index.Synergy	162
abstract_inverted_index.absence	93
abstract_inverted_index.average	124
abstract_inverted_index.fixing,	79
abstract_inverted_index.models.	22
abstract_inverted_index.synergy	236
abstract_inverted_index.treated	55, 180
abstract_inverted_index.Combined	2
abstract_inverted_index.compared	121
abstract_inverted_index.control.	41, 155
abstract_inverted_index.generate	239
abstract_inverted_index.imaging.	82
abstract_inverted_index.matrices	163
abstract_inverted_index.plotted.	46, 160
abstract_inverted_index.presence	35, 95, 149
abstract_inverted_index.toxicity	3, 111
abstract_inverted_index.Long-term	48
abstract_inverted_index.calculate	233
abstract_inverted_index.condition	216
abstract_inverted_index.controls.	226
abstract_inverted_index.estimated	26, 140, 218
abstract_inverted_index.indicated	62, 104
abstract_inverted_index.refreshed	66
abstract_inverted_index.resazurin	28, 142, 220
abstract_inverted_index.staining,	80
abstract_inverted_index.viability	24, 49, 138, 213
abstract_inverted_index.Treatments	64
abstract_inverted_index.normalized	43, 157, 223
abstract_inverted_index.percentage	210
abstract_inverted_index.respective	204
abstract_inverted_index.Adavosertib	7, 18, 59, 115, 172, 194
abstract_inverted_index.combination	101, 168
abstract_inverted_index.Adavosertib,	98
abstract_inverted_index.fluorescence	29, 143, 221
abstract_inverted_index.permutations	205
abstract_inverted_index.Dose-response	12, 107
abstract_inverted_index.proliferation	85
abstract_inverted_index.supplementary	134
abstract_inverted_index.IncuCyte-based	84
abstract_inverted_index.concentrations	183
abstract_inverted_index.<p>Figure	0
abstract_inverted_index.concentrations.	63, 105
abstract_inverted_index.plots.</p>	241
abstract_inverted_index.Synergyfinder.org	227
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	38
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.7099999785423279
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.21683153
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False